102 related articles for article (PubMed ID: 6128992)
1. Use of metyrosine in the anaesthetic management of patients with catecholamine-secreting tumours. A case report.
Triner L; Baer L; Gallagher R; Weitzman S
Br J Anaesth; 1982 Dec; 54(12):1333-6. PubMed ID: 6128992
[TBL] [Abstract][Full Text] [Related]
2. Failure of metyrosine therapy for preoperative management of pheochromocytoma: a case report.
Thanapaalasingham K; Pollmann AS; Schelew B
Can J Anaesth; 2015 Dec; 62(12):1303-7. PubMed ID: 26362800
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of pheochromocytoma with the use of metyrosine.
Perry RR; Keiser HR; Norton JA; Wall RT; Robertson CN; Travis W; Pass HI; Walther MM; Linehan WM
Ann Surg; 1990 Nov; 212(5):621-8. PubMed ID: 1978640
[TBL] [Abstract][Full Text] [Related]
4. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
Kuchel O; Buu NT; Edwards DJ
J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
[TBL] [Abstract][Full Text] [Related]
5. Metyrosine and pheochromocytoma.
Steinsapir J; Carr AA; Prisant LM; Bransome ED
Arch Intern Med; 1997 Apr; 157(8):901-6. PubMed ID: 9129550
[TBL] [Abstract][Full Text] [Related]
6. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma.
Ram CV; Meese R; Hill SC
Arch Intern Med; 1985 Nov; 145(11):2114-5. PubMed ID: 2865938
[TBL] [Abstract][Full Text] [Related]
7. Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study.
Takekoshi K; Satoh F; Tanabe A; Okamoto T; Ichihara A; Tsuiki M; Katabami T; Nomura M; Tanaka T; Matsuda T; Imai T; Yamada M; Asada S; Kawata N; Naruse M
Endocr J; 2019 Dec; 66(12):1063-1072. PubMed ID: 31511435
[TBL] [Abstract][Full Text] [Related]
8. Catecholamine-secreting infratemporal fossa paraganglioma.
Cantrell RW; Kaplan MJ; Atuk NO; Winn HR; Jahrsdoerfer RA
Ann Otol Rhinol Laryngol; 1984; 93(6 Pt 1):583-8. PubMed ID: 6095720
[TBL] [Abstract][Full Text] [Related]
9. Catecholamine depletion produces irrepressible saccadic eye movements in normal humans.
Tychsen L; Sitaram N
Ann Neurol; 1989 May; 25(5):444-9. PubMed ID: 2570547
[TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic effects of norepinephrine inhibition in patients with severe chronic congestive heart failure.
Franciosa JA; Schwartz DE
J Am Coll Cardiol; 1989 Sep; 14(3):624-30. PubMed ID: 2570091
[TBL] [Abstract][Full Text] [Related]
11. Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.
Timmers HJ; Pacak K; Huynh TT; Abu-Asab M; Tsokos M; Merino MJ; Baysal BE; Adams KT; Eisenhofer G
J Clin Endocrinol Metab; 2008 Dec; 93(12):4826-32. PubMed ID: 18840642
[TBL] [Abstract][Full Text] [Related]
12. [A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)].
Okada S; Ohshima K; Onai T; Umahara M; Kobayashi S; Ishihara H
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1221-5. PubMed ID: 1975832
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan.
Naruse M; Satoh F; Tanabe A; Okamoto T; Ichihara A; Tsuiki M; Katabami T; Nomura M; Tanaka T; Matsuda T; Imai T; Yamada M; Harada T; Kawata N; Takekoshi K
Endocr J; 2018 Mar; 65(3):359-371. PubMed ID: 29353821
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma.
Imperato-McGinley J; Gautier T; Ehlers K; Zullo MA; Goldstein DS; Vaughan ED
N Engl J Med; 1987 Mar; 316(13):793-7. PubMed ID: 2881206
[No Abstract] [Full Text] [Related]
15. An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside.
Anton AH; Sherman BW; Lina AA; Acheson LS
Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):89-92. PubMed ID: 8096204
[TBL] [Abstract][Full Text] [Related]
16. Perioperative management of a patient with a malignant pheochromocytoma.
Miller D; Robblee JA
Can Anaesth Soc J; 1985 May; 32(3 Pt 1):278-82. PubMed ID: 4005679
[TBL] [Abstract][Full Text] [Related]
17. [An autopsy case of extra-adrenal malignant pheochromocytoma].
Sunaga Y; Taniguchi N; Hayashi K; Koito M; Inada M; Oyaizu N; Shikata N
Gan No Rinsho; 1990 Sep; 36(11):2092-9. PubMed ID: 1977940
[TBL] [Abstract][Full Text] [Related]
18. Insulin release pattern after blockade of catecholamine synthesis with alpha-methyl tyrosine in vivo.
Mills J; Melville GN; Bennett C; Robinson H; Castro A
Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):97-106. PubMed ID: 6147884
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
van Duinen N; Corssmit EP; de Jong WH; Brookman D; Kema IP; Romijn JA
Eur J Endocrinol; 2013 Sep; 169(3):377-82. PubMed ID: 23832865
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in the diagnosis and treatment of pheochromocytoma.
Sheps SG; Jiang NS; Klee GG; van Heerden JA
Mayo Clin Proc; 1990 Jan; 65(1):88-95. PubMed ID: 1967325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
